Novo Nordisk Pink Sheet Forecast - Relative Strength Index
| NONOF Stock | USD 62.25 0.03 0.05% |
Novo Pink Sheet Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Novo Nordisk's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 24th of January 2026 the relative strength index (rsi) of Novo Nordisk's share price is below 20 . This indicates that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Novo Nordisk hype-based prediction, you can estimate the value of Novo Nordisk AS from the perspective of Novo Nordisk response to recently generated media hype and the effects of current headlines on its competitors.
Novo Nordisk after-hype prediction price | USD 62.24 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Novo |
Novo Nordisk Additional Predictive Modules
Most predictive techniques to examine Novo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Novo using various technical indicators. When you analyze Novo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check Novo Nordisk Volatility | Backtest Novo Nordisk | Information Ratio |
Novo Nordisk Trading Date Momentum
| On January 23 2026 Novo Nordisk AS was traded for 62.25 at the closing time. The highest daily price throughout the period was 63.85 and the lowest price was 62.10 . The daily volume was 1.6 K. The net trading volume on 01/23/2026 did not cause price change. The trading delta at closing time to current closing price is 2.55% . |
| Compare Novo Nordisk to competition |
Other Forecasting Options for Novo Nordisk
For every potential investor in Novo, whether a beginner or expert, Novo Nordisk's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Novo Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Novo. Basic forecasting techniques help filter out the noise by identifying Novo Nordisk's price trends.Novo Nordisk Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Novo Nordisk pink sheet to make a market-neutral strategy. Peer analysis of Novo Nordisk could also be used in its relative valuation, which is a method of valuing Novo Nordisk by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Novo Nordisk Market Strength Events
Market strength indicators help investors to evaluate how Novo Nordisk pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Novo Nordisk shares will generate the highest return on investment. By undertsting and applying Novo Nordisk pink sheet market strength indicators, traders can identify Novo Nordisk AS entry and exit signals to maximize returns.
Novo Nordisk Risk Indicators
The analysis of Novo Nordisk's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Novo Nordisk's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting novo pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.49 | |||
| Semi Deviation | 2.54 | |||
| Standard Deviation | 3.28 | |||
| Variance | 10.78 | |||
| Downside Variance | 7.5 | |||
| Semi Variance | 6.45 | |||
| Expected Short fall | (2.86) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Novo Nordisk
The number of cover stories for Novo Nordisk depends on current market conditions and Novo Nordisk's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Novo Nordisk is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Novo Nordisk's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Additional Information and Resources on Investing in Novo Pink Sheet
When determining whether Novo Nordisk AS offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Novo Nordisk's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Novo Nordisk As Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Novo Nordisk As Stock:Check out Historical Fundamental Analysis of Novo Nordisk to cross-verify your projections. You can also try the AI Portfolio Prophet module to use AI to generate optimal portfolios and find profitable investment opportunities.